| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4295482
[patent_doc_number] => 06197764
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Clozapine compositions and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/978541
[patent_app_country] => US
[patent_app_date] => 1997-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4877
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197764.pdf
[firstpage_image] =>[orig_patent_app_number] => 978541
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/978541 | Clozapine compositions and uses thereof | Nov 25, 1997 | Issued |
Array
(
[id] => 3981564
[patent_doc_number] => 05948886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides'
[patent_app_type] => 1
[patent_app_number] => 8/978096
[patent_app_country] => US
[patent_app_date] => 1997-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15389
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948886.pdf
[firstpage_image] =>[orig_patent_app_number] => 978096
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/978096 | Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides | Nov 24, 1997 | Issued |
| 08/975551 | CYTOKINE REGULATORY AGENTS AND METHODS OF USE IN PATHOLOGIES AND CONDITIONS ASSOCIATED WITH ALTERED CYTOKINE LEVELS | Nov 19, 1997 | Abandoned |
Array
(
[id] => 4410396
[patent_doc_number] => 06228858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Advanced glycation end-product intermediaries and post-amadori inhibition'
[patent_app_type] => 1
[patent_app_number] => 8/971285
[patent_app_country] => US
[patent_app_date] => 1997-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 85
[patent_no_of_words] => 20459
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228858.pdf
[firstpage_image] =>[orig_patent_app_number] => 971285
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/971285 | Advanced glycation end-product intermediaries and post-amadori inhibition | Nov 16, 1997 | Issued |
Array
(
[id] => 3928844
[patent_doc_number] => 05952502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => '2R,4S,R, S- and 2S,4R,R,S-hydroxyitraconazole'
[patent_app_type] => 1
[patent_app_number] => 8/968780
[patent_app_country] => US
[patent_app_date] => 1997-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6715
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/952/05952502.pdf
[firstpage_image] =>[orig_patent_app_number] => 968780
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/968780 | 2R,4S,R, S- and 2S,4R,R,S-hydroxyitraconazole | Nov 11, 1997 | Issued |
Array
(
[id] => 4367748
[patent_doc_number] => 06274552
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Composition and method for delivery of biologically-active factors'
[patent_app_type] => 1
[patent_app_number] => 8/966940
[patent_app_country] => US
[patent_app_date] => 1997-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10517
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274552.pdf
[firstpage_image] =>[orig_patent_app_number] => 966940
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/966940 | Composition and method for delivery of biologically-active factors | Nov 9, 1997 | Issued |
| 08/945801 | PHARMACEUTICAL ADMINISTRATION FORM OF PARATHYROID HORMONE HAVING AN ACTIVE INGREDIENT RELEASE PERIOD OF FROM TWO TO SIX HOURS | Nov 9, 1997 | Abandoned |
Array
(
[id] => 4406109
[patent_doc_number] => 06271198
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Constrained helical peptides and methods of making same'
[patent_app_type] => 1
[patent_app_number] => 8/965056
[patent_app_country] => US
[patent_app_date] => 1997-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 40
[patent_no_of_words] => 88868
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 521
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271198.pdf
[firstpage_image] =>[orig_patent_app_number] => 965056
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/965056 | Constrained helical peptides and methods of making same | Nov 4, 1997 | Issued |
| 08/793616 | USE OF PARACELLULAR ABSORPTION ENHANCERS SUCH AS GLUCOSE FOR ENHAINCING THE ABSORPTION OF HISTAMINE H2-ANTAGONISTS | Oct 29, 1997 | Abandoned |
Array
(
[id] => 4237146
[patent_doc_number] => 06165977
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Isozyme-specific activators of protein kinase C methods and compositions'
[patent_app_type] => 1
[patent_app_number] => 8/953033
[patent_app_country] => US
[patent_app_date] => 1997-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 32
[patent_no_of_words] => 15060
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/165/06165977.pdf
[firstpage_image] =>[orig_patent_app_number] => 953033
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/953033 | Isozyme-specific activators of protein kinase C methods and compositions | Oct 16, 1997 | Issued |
Array
(
[id] => 4290728
[patent_doc_number] => 06211335
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Method of tissue repair'
[patent_app_type] => 1
[patent_app_number] => 8/875228
[patent_app_country] => US
[patent_app_date] => 1997-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 6382
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211335.pdf
[firstpage_image] =>[orig_patent_app_number] => 875228
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/875228 | Method of tissue repair | Oct 16, 1997 | Issued |
Array
(
[id] => 4271542
[patent_doc_number] => 06245742
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use'
[patent_app_type] => 1
[patent_app_number] => 8/930616
[patent_app_country] => US
[patent_app_date] => 1997-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 16081
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245742.pdf
[firstpage_image] =>[orig_patent_app_number] => 930616
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/930616 | Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use | Oct 14, 1997 | Issued |
Array
(
[id] => 4271446
[patent_doc_number] => 06245736
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer\'s disease'
[patent_app_type] => 1
[patent_app_number] => 8/949496
[patent_app_country] => US
[patent_app_date] => 1997-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5519
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245736.pdf
[firstpage_image] =>[orig_patent_app_number] => 949496
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/949496 | Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease | Oct 13, 1997 | Issued |
Array
(
[id] => 4046718
[patent_doc_number] => 05912328
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Method for the removal of viruses from protein solutions'
[patent_app_type] => 1
[patent_app_number] => 8/946024
[patent_app_country] => US
[patent_app_date] => 1997-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3353
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912328.pdf
[firstpage_image] =>[orig_patent_app_number] => 946024
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/946024 | Method for the removal of viruses from protein solutions | Oct 6, 1997 | Issued |
Array
(
[id] => 4102615
[patent_doc_number] => 06066716
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Purified heat shock protein complexes'
[patent_app_type] => 1
[patent_app_number] => 8/934139
[patent_app_country] => US
[patent_app_date] => 1997-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2305
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066716.pdf
[firstpage_image] =>[orig_patent_app_number] => 934139
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/934139 | Purified heat shock protein complexes | Sep 18, 1997 | Issued |
Array
(
[id] => 3926225
[patent_doc_number] => 05945507
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Antimicrobial peptides'
[patent_app_type] => 1
[patent_app_number] => 8/932682
[patent_app_country] => US
[patent_app_date] => 1997-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21321
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945507.pdf
[firstpage_image] =>[orig_patent_app_number] => 932682
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/932682 | Antimicrobial peptides | Sep 17, 1997 | Issued |
Array
(
[id] => 4108895
[patent_doc_number] => 06057294
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-02
[patent_title] => 'Peptide'
[patent_app_type] => 1
[patent_app_number] => 8/875013
[patent_app_country] => US
[patent_app_date] => 1997-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8645
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/057/06057294.pdf
[firstpage_image] =>[orig_patent_app_number] => 875013
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/875013 | Peptide | Sep 14, 1997 | Issued |
Array
(
[id] => 3945618
[patent_doc_number] => 05977071
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Glucagon-like insulinotropic peptides, compositions and methods'
[patent_app_type] => 1
[patent_app_number] => 8/927227
[patent_app_country] => US
[patent_app_date] => 1997-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6797
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977071.pdf
[firstpage_image] =>[orig_patent_app_number] => 927227
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/927227 | Glucagon-like insulinotropic peptides, compositions and methods | Sep 9, 1997 | Issued |
Array
(
[id] => 3933384
[patent_doc_number] => 05939390
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-17
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => 1
[patent_app_number] => 8/925708
[patent_app_country] => US
[patent_app_date] => 1997-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7702
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/939/05939390.pdf
[firstpage_image] =>[orig_patent_app_number] => 925708
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/925708 | Pharmaceutical composition | Sep 8, 1997 | Issued |
Array
(
[id] => 4240296
[patent_doc_number] => 06166184
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Process for making a bioprosthetic device'
[patent_app_type] => 1
[patent_app_number] => 8/912778
[patent_app_country] => US
[patent_app_date] => 1997-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11709
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166184.pdf
[firstpage_image] =>[orig_patent_app_number] => 912778
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/912778 | Process for making a bioprosthetic device | Aug 17, 1997 | Issued |